glp-1 olympia Agonists for Weight Loss Are you taking GLP-1s for
Description
Over the last few years, overweight and ...
We ran a synthetic panel on GLP-1s impact on food and beverage categories
Female GLP-1RA users showed increased HSV risk (HR=1.51), and poorly controlled patients (HbA1c7%) had higher HSV risks (HR=1.195)
Group one included patients with moderate PAD who were started on GLP-1 RAs, and group two included patients with moderate PAD who were not started on GLP-1 RAs. At one year, patients with moderate PAD who were started on GLP-1 RAs had fewer major adverse limb events (MALE) (0.8% vs 1.5%), major adverse cardiac events (MACE) (25.4% vs 29.3%), and decreased risk of hospitalizations (17.9 vs 26.8%)
What is the evidence base for retatrutide
